Icu Hospital Articles & Analysis
15 news found
In the report, VRE was said to have caused an estimated 54,500 infections among hospitalized patients and 5,400 estimated deaths in the United States in 2017 alone. Some of the patients listed by CDC as being at high risk for VRE infections include those undergoing complex or prolonged healthcare, such as patients in long-term acute care hospitals or ...
In this publication titled “Fast multiplex bacterial PCR of bronchoalveolar lavage for antibiotic stewardship in hospitalized patients with pneumonia at risk of Gram-negative bacterial infection (Flagship II): a multicentre, randomized controlled trial1,” the authors assessed the clinical utility and impact of the Unyvero panel in hospitalized adult ...
Based on the positive data to-date, we believe LB1148 has the potential to truly establish the standard of care and provide hospitals with a potentially safe solution to accelerate patient discharge. ...
By inhibiting the activity of these digestive proteases, LB1148 has the potential to prevent damage to GI tissues, accelerate the time to the return of normal GI function, and shorten the duration of costly post-surgery hospital stays. The U.S. FDA has granted Fast Track designation to LB1148 for two clinical indications: reduction of adhesions following abdominal or pelvic ...
Positive data from Phase 2 clinical trials of LB1148 demonstrated safety and tolerability as well as a statistically significant improvement in the return of bowel function and a decrease in the length of stay in ICU and hospital compared to placebo. Plans are underway to commence a pivotal, Phase 3 study of LB1148 in the second half of 2022. ...
By inhibiting the activity of these digestive proteases, LB1148 has the potential to prevent damage to GI tissues, accelerate the time to return of normal GI function, and shorten the duration of costly post-surgery hospital stays. About Palisade Bio Palisade Bio is a clinical stage biopharmaceutical company advancing therapies that aid patients suffering with acute and ...
By inhibiting the activity of these digestive proteases, LB1148 has the potential to prevent damage to GI tissues, accelerate the time to return of normal GI function, and shorten the duration of costly post-surgery hospital stays. About Palisade Bio Palisade Bio is a clinical stage biopharmaceutical company advancing therapies that help patients with acute and chronic ...
Positive data from Phase 2 trials of LB1148 demonstrated safety and tolerability as well as a statistically significant improvement in return to bowel function and decrease in length of stay in ICU and hospital compared to placebo. Palisade Bio believes that its investigational therapies have the potential to address the myriad health conditions and complications ...
Positive data from Phase 2 trials of LB1148 demonstrated safety and tolerability as well as a statistically significant improvement in return to bowel function and decrease in length of stay in ICU and hospital compared to placebo. Palisade Bio believes that its investigational therapies have the potential to address the myriad health conditions and complications ...
The cSOFA score (Covid Sequential Organ Failure Assessment) measures the likelihood of clinical deterioration in Covid-19 patients, enabling triage and assignment to the general ward or intensive care units (ICU) upon admission and during the patients’ hospital stay. A low score allows medical decisions to be made on safely discharging patients from the ...
Howard Carolan, CEO and Co-Founder, states: “We have been receiving fantastic feedback from hospitals in our initial launch program, which is using the PUMA-G System to revolutionize feeding tube placement. ...
ByCoapTech
Reducing the time patients spend on mechanical ventilation may reduce the risks of prolonged mechanical ventilation, which include hospital acquired infections, deteriorated quality of life and death. Fewer days on ventilation may also increase the availability of ventilators during the COVID-19 pandemic. Two pilot randomized controlled trials, recently completed in Europe and ...
The round was led by Pierangelo Bottinelli, Chairman of Symphony International Holdings Limited, and included Philippe Glatz (Chairman of two private hospitals), Peter Brabeck-Letmathe (former CEO and Chairman of Nestlé), Arkady Volozh (Co-Founder and CEO of Yandex), Jean-Bernard and Nelson Dumas (Owners of Dumas Construction), Investiere AG and Zürcher Kantonalbank. ...
Update by Dr J Gallagher, Employment health Advisors (EHA): Influenza activity decreased in Ireland during week 11 2014, however remained at elevated levels, with continuing reports of confirmed influenza hospital and ICU admissions and outbreaks. Influenza A(H3) is the predominant virus circulating. ...
Update by Dr J Gallagher, Employment Health Advisors (EHA): Influenza activity remained at elevated levels in Ireland during week 9 2014, with continuing reports of confirmed influenza hospital and ICU admissions and outbreaks. Influenza A(H3) is the predominant virus circulating, and is co-circulating with influenza A(H1)pdm09. ...